Episode Details

SpaceX is pushing ahead with its initial public offering plans – a bid to raise some $30 billion and land in the $1.5 trillion club – while the biotech sector has seen the most mergers and acquisitions in a decade, as pharma firms race against an expiry date.

Today’s stories:

• SpaceX Is Preparing For Its Public Market Launch Day
• Pharma Firms Rushed To Restock Before Their Pipelines Run Dry

Try Finimize Pro